GlassScriptPhysician profile
Ashley N Harris
NPI 1730671488
$5,349.13
in general payments reported to CMS, 2019-2025
60 companies · $1,495 in 2025
The $1,495 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $361 · 2022: $683 · 2023: $1,743 · 2024: $1,067 · 2025: $1,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,060 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,059.97 |
| Education | $245.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $855.21 | 2023-2024 | Cabometyx |
| Daiichi Sankyo INC. | $635.68 | 2021-2025 | Enhertu, Datroway, Vanflyta |
| Novartis Pharmaceuticals Corporation | $469.47 | 2021-2025 | |
| Genzyme Corporation | $279.13 | 2021-2025 | |
| Janssen Biotech, INC. | $256.87 | 2022-2025 | Rybrevant, Talvey, Erleada |
| Astrazeneca Pharmaceuticals LP | $250.14 | 2022-2025 | Enhertu, Imfinzi, Calquence |
| Takeda Pharmaceuticals U.S.A., INC. | $232.47 | 2023-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Pfizer INC. | $215.45 | 2021-2025 | |
| Incyte Corporation | $125.33 | 2022-2025 | Jakafi |
| Merck Sharp & Dohme LLC | $120.16 | 2023-2025 | Keytruda, Welireg |
| Tempus Ai, INC | $109.87 | 2024-2025 | Xt Cdx |
| Eisai INC. | $109.72 | 2021-2025 | |
| Novocure INC. | $104.04 | 2024-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Macrogenics, INC. | $93.12 | 2022 | |
| Genentech USA, INC. | $78.94 | 2021-2025 | Polivy, Itovebi, Alecensa |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.